Per Svangren is an author at AstraZeneca (Netherlands) specializing in atherosclerosis, metabolic syndrome, and cardiovascular disease.
Top concepts
HealthMedicinePublic HealthAtherosclerosisHealth EconomicsMetabolic SyndromePreventive MedicineCardiovascular Disease
Publications per year
2003–2019
2
2
Rows per page
1–2 of 2